CRI Launches Spanish-Language Resource Hub This 9th annual Cancer Immunotherapy Month™, CRI aims to help close the information and research gap to... June 25, 2021July 13, 2022
CRI Lanza Su Website Como Centro De Información En Español En conmemoración del 9o aniversario del Mes de la Inmunoterapia contra el Cáncer, el CRI tiene como... June 25, 2021July 1, 2022
CRI Celebrates Diversity During 9th Cancer Immunotherapy Month in June Cancer Research Institute celebrates progress in cancer immunotherapy research, announces new initiatives aimed at addressing racial and ethnic... May 25, 2021July 13, 2022
CRI Celebrates Diversity During 9th Cancer Immunotherapy Month in June En junio, al celebrar el noveno Mes de la inmunoterapia, el Cancer Research Institute conmemora los avances... May 25, 2021July 1, 2022
CRI and RevImmune Announce Dosing of First Patient in New Phase 2 Study First study to test RevImmune’s IL-7 drug candidate in cancer patients infected with the SARS-CoV-2 coronavirus at... March 30, 2021July 13, 2022
CRI and RevImmune Announce Dosing of First Patient in New Phase 2 Study Primer estudio en probar la IL-7 de RevImmune, un fármaco de interés médico, en pacientes con cáncer... March 30, 2021July 1, 2022
